| # | Drug | Count |
|---|---|---|
| 0 | LENALIDOMIDE | 26 |
| 1 | BORTEZOMIB | 21 |
| 2 | DEXAMETHASONE | 20 |
| 3 | DEXAMETHASONE 1.5 MG | 20 |
| 4 | PREDNISONE | 12 |
| 5 | RITUXIMAB | 11 |
| 6 | CYCLOPHOSPHAMIDE | 10 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 10 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 10 |
| 9 | ADALIMUMAB | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZOPAPOGENE IMADENOVEC | 1 | 0.0250 |
| 1 | PIRTOBRUTINIB | 4 | 0.0041 |
| 2 | NINTEDANIB ESYLATE | 1 | 0.0029 |
| 3 | COLISTIMETHATE SODIUM | 4 | 0.0025 |
| 4 | CILTACABTAGENE AUTOLEUCEL | 8 | 0.0012 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 8 | 0.0010 |
| 6 | RILONACEPT | 1 | 0.0009 |
| 7 | SENNOSIDES A AND B | 1 | 0.0006 |
| 8 | POLATUZUMAB VEDOTIN | 5 | 0.0005 |
| 9 | BRODALUMAB | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 1 | Cytolytic Agent [EPC] | 1 | 0.0004 |
| 2 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 3 | Recombinant Human Deoxyribonuclease 1 [EPC] | 4 | 0.0002 |
| 4 | Proteasome Inhibitor [EPC] | 23 | 0.0002 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 15 | 0.0002 |
| 6 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 7 | CTLA-4-directed Blocking Antibody [EPC] | 6 | 0.0001 |
| 8 | Glycopeptide Antibacterial [EPC] | 8 | 0.0001 |
| 9 | PCSK9 Inhibitor [EPC] | 3 | 0.0001 |